Vozzhaev A.V. - list of publications

МНОГОФАКТОРНЫЙ АНАЛИЗ ПРИВЕРЖЕННОСТИ ФАРМАКОТЕРАПИИ СРЕДИ АМБУЛАТОРНЫХ ПАЦИЕНТОВ СО СТАБИЛЬНОЙ ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА

Article

Фитилёв С.Б., Возжаев А.В., Клюев Д.А., Шкребнёва И.И.

Качественная клиническая практика. Общество с ограниченной ответственностью Издательство ОКИ. 2021. P. 44-52

MULTIVARIABLE ANALYSIS OF PRIMARY CARE PHYSICIAN ADHERENCE TO GUIDELINE-RECOMMENDED PHARMACOTHERAPY OF STABLE CORONARY ARTERY DISEASE

Article

Zyryanov S.K., Fitilev S.B., Vozzhaev A.V., Shkrebniova I.I.

Rational Pharmacotherapy in Cardiology. Stolichnaya Izdatelskaya Kompaniya. Vol. 17. 2021. P. 29-35

CRITICAL ASPECTS OF THE MANAGEMENT OF STABLE CORONARY ARTERY DISEASE IN PRIMARY CARE PRACTICE OR HOW TO INCREASE THE EFFICACY OF EVIDENCE-BASED PHARMACOLOGICAL THERAPY?

Article

Zyryanov S.K., Fitilev S.B., Vozzhaev A.V., Shkrebniova I.I., Klyuev D.A.

Research Results in Pharmacology. Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет". Vol. 6. 2020. P. 15-20

IMPLEMENTATION OF THE CONCEPT OF STANDARD OPERATING PROCEDURES INTO PRIMARY CARE PRACTICE: UTOPIA OR URGENT NEED?

Article

Зырянов С.К., Фитилев С.Б., Возжаев А.В., Шкребнева И.И., Тяжельников А.А., Шиндряева Н.Н.

Качественная клиническая практика. Общество с ограниченной ответственностью Издательство ОКИ. 2020. P. 75-84

MEDICATION ADHERENCE IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE IN PRIMARY CARE

Article

Zyryanov S.K., Fitilev S.B., Vozzhaev A.V., Shkrebniova I.I., Shindryaeva N.N., Klyuev D.A., Stepanyan L.N., Landyshev N.N., Voronko Y.G.

Research Results in Pharmacology. Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет". Vol. 6. 2020. P. 97-103

LIPID-LOWERING THERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE IN PRIMARY CARE PRACTICES: WHAT HAS CHANGED OVER 7 YEARS?

Article

Зырянов С.К., Фитилев С.Б., Возжаев А.В., Шкребнева И.И., Клюев Д.А., Степанян Л.Н., Данилова А.А., Цай А.Т., Ландышев Н.Н., Воронько Я.Г.

Cardiovascular Therapy and Prevention (Russian Federation). Vserossiiskoe Obshchestvo Kardiologov. Vol. 19. 2020. P. 78-86

LIPID-LOWERING THERAPY IN OUTPATIENTS OF DIFFERENT AGES WITH CORONARY ARTERY DISEASE

Article

Zyryanov S.K., Fitilev S.B., Vozzhaev A.V., Shkrebneva I.I., Landyshev N.N., Voronko Ya.G., Lutsenko A.M.

Cardiovascular Therapy and Prevention (Russian Federation). Vserossiiskoe Obshchestvo Kardiologov. Vol. 19. 2020. P. 75-82

RESULTS OF A PHASE I OPEN RANDOMIZED COMPARATIVE CROSSOVER CLINICAL TRIAL TO ASSESS THE SAFETY AND PHARMACOKINETICS OF GLURAZIM® (IMIGLUCERASE) IN COMPARISON WITH THE REFERENCE PRODUCT IN HEALTHY VOLUNTEERS

Article

Fitilev S.B., Vozzhaev A.V., Shkrebneva I.I., Kudlay D.A., Gapchenko E.V., Markova O.A., Borozinets A.Y., Kazarov A.A., Pantyushenko M.S.

Онкогематология. Общество с ограниченной ответственностью "Издательский дом "АБВ-пресс". Vol. 14. 2019. P. 73-83

MEDICATION ADHERENCE IN PATIENTS WITH CARDIOVASCULAR DISEASE: CURRENT VIEW OF THE PROBLEM

Article

Fitilev S.B., Vozzhaev A.V., Shkrebniova I.I., Kliuev D.A., Stepanyan L.N.

Качественная клиническая практика. Общество с ограниченной ответственностью Издательство ОКИ. 2019. P. 66-80

RESULTS OF A PHASE I OPEN RANDOMIZED COMPARATIVE CROSSOVER CLINICAL TRIAL TO ASSESS THE SAFETY AND PHARMACOKINETICS OF G LURAZYME® (IMIGLUCERASE) IN COMPARISON WITH THE REFERENCE PRODUCT IN HEALTHY VOLUNTEERS

Article

Fitilev S.B., Vozzhaev A.V., Shkrebneva I.I., Kudlay D.A., Gapchenko E.V., Markova O.A., Borozinets A.Y., Kazarov A.A., Pantyushenko M.S.

Онкогематология. Общество с ограниченной ответственностью "Издательский дом "АБВ-пресс". Vol. 14. 2019. P. 73-83

THE ROLE OF REFERENCE INTERVALS OF LABORATORY TESTS IN EARLY PHASE CLINICAL RESEARCH IN HEALTHY VOLUNTEERS

Article

Fitilev S.B., Vozzhaev A.V., Shkrebniova I.I., Kliuev D.A., Vdovina A.A., Miasnikova L.A.

Качественная клиническая практика. Общество с ограниченной ответственностью Издательство ОКИ. 2018. P. 64-71

ANALYSIS OF CHANGES IN PHARMACOTHERAPY OF STABLE ANGINA OVER THE FIVE-YEAR PERIOD AT SPECIALIZED OUT-PATIENT LEVEL OF MEDICAL CARE (PHARMACOEPIDEMIOLOGICAL STUDY)

Article

Tsukanova K.O., Fitilev S.B., Vozzhaev A.V., Shkrebneva I.I., Klyuev D.A.

Research Results in Pharmacology. Федеральное государственное автономное образовательное учреждение высшего образования "Белгородский государственный национальный исследовательский университет". Vol. 4. 2018. P. 47-58

FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY)

Article

Fitilev S.B., Shkrebneva I.I., Vozzhaev A.V., Tsukanova K.O.

Rational Pharmacotherapy in Cardiology. Stolichnaya Izdatelskaya Kompaniya. Vol. 14. 2018. P. 244-251

THE PROBLEM OF OVER-VOLUNTEERING IN EARLY PHASE CLINICAL TRIALS

Article

Fitilev S.B., Vozzhaev A.V., Shkrebniova I.I., Kliuev D.A.

Качественная клиническая практика. Общество с ограниченной ответственностью Издательство ОКИ. 2018. P. 58-63

DRUG INTERCHANGEABILITY: CLINICAL EFFICACY AND SAFETY

Article

Zyryanov S.K., Fitilev S.B., Shkrebneva I.I., Vozzhaev A.V.

Nevrologiya, Neiropsikhiatriya, Psikhosomatika. Ima-Press Publishing House. Vol. 9. 2017. P. 4-10

Возжаев А.В.

List of records

МНОГОФАКТОРНЫЙ АНАЛИЗ ПРИВЕРЖЕННОСТИ ФАРМАКОТЕРАПИИ СРЕДИ АМБУЛАТОРНЫХ ПАЦИЕНТОВ СО СТАБИЛЬНОЙ ИШЕМИЧЕСКОЙ БОЛЕЗНЬЮ СЕРДЦА

MULTIVARIABLE ANALYSIS OF PRIMARY CARE PHYSICIAN ADHERENCE TO GUIDELINE-RECOMMENDED PHARMACOTHERAPY OF STABLE CORONARY ARTERY DISEASE

CRITICAL ASPECTS OF THE MANAGEMENT OF STABLE CORONARY ARTERY DISEASE IN PRIMARY CARE PRACTICE OR HOW TO INCREASE THE EFFICACY OF EVIDENCE-BASED PHARMACOLOGICAL THERAPY?

IMPLEMENTATION OF THE CONCEPT OF STANDARD OPERATING PROCEDURES INTO PRIMARY CARE PRACTICE: UTOPIA OR URGENT NEED?

MEDICATION ADHERENCE IN PATIENTS WITH STABLE CORONARY ARTERY DISEASE IN PRIMARY CARE

LIPID-LOWERING THERAPY IN PATIENTS WITH CORONARY ARTERY DISEASE IN PRIMARY CARE PRACTICES: WHAT HAS CHANGED OVER 7 YEARS?

LIPID-LOWERING THERAPY IN OUTPATIENTS OF DIFFERENT AGES WITH CORONARY ARTERY DISEASE

RESULTS OF A PHASE I OPEN RANDOMIZED COMPARATIVE CROSSOVER CLINICAL TRIAL TO ASSESS THE SAFETY AND PHARMACOKINETICS OF GLURAZIM® (IMIGLUCERASE) IN COMPARISON WITH THE REFERENCE PRODUCT IN HEALTHY VOLUNTEERS

MEDICATION ADHERENCE IN PATIENTS WITH CARDIOVASCULAR DISEASE: CURRENT VIEW OF THE PROBLEM

RESULTS OF A PHASE I OPEN RANDOMIZED COMPARATIVE CROSSOVER CLINICAL TRIAL TO ASSESS THE SAFETY AND PHARMACOKINETICS OF G LURAZYME® (IMIGLUCERASE) IN COMPARISON WITH THE REFERENCE PRODUCT IN HEALTHY VOLUNTEERS

THE ROLE OF REFERENCE INTERVALS OF LABORATORY TESTS IN EARLY PHASE CLINICAL RESEARCH IN HEALTHY VOLUNTEERS

ANALYSIS OF CHANGES IN PHARMACOTHERAPY OF STABLE ANGINA OVER THE FIVE-YEAR PERIOD AT SPECIALIZED OUT-PATIENT LEVEL OF MEDICAL CARE (PHARMACOEPIDEMIOLOGICAL STUDY)

FIVE-YEAR DYNAMICS OF SECONDARY PREVENTION IN PATIENTS WITH STABLE ANGINA AT SPECIALIZED OUT-PATIENT LEVEL IN MOSCOW (PHARMACOEPIDEMIOLOGY STUDY)

THE PROBLEM OF OVER-VOLUNTEERING IN EARLY PHASE CLINICAL TRIALS

DRUG INTERCHANGEABILITY: CLINICAL EFFICACY AND SAFETY

Other authors

Shkrebneva I.I.

Popaduyk V.I.